Terms: = Breast cancer AND TOP2A, TOP2, TP2A AND Prognosis
58 results:
1. The correlation study between top2a gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer.
Ye JH; Yu J; Huang MY; Mo YM
Breast Cancer; 2024 May; 31(3):417-425. PubMed ID: 38561479
[TBL] [Abstract] [Full Text] [Related]
2. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating top2a.
Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer.
Ren X; Song Y; Pang J; Chen L; Zhou L; Liang Z; Wu H
Front Immunol; 2023; 14():1137561. PubMed ID: 37090736
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer.
Zeng Y; Ma W; Li L; Zhuang G; Luo G; Zhou H; Hao W; Liu Y; Guo F; Tian M; Ruan X; Gao M; Zheng X
Aging (Albany NY); 2023 Mar; 15(5):1668-1684. PubMed ID: 36917092
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the causality and pathogenesis of systemic lupus erythematosus in breast cancer based on Mendelian randomization and transcriptome data analyses.
Li W; Wang R; Wang W
Front Immunol; 2022; 13():1029884. PubMed ID: 36726984
[TBL] [Abstract] [Full Text] [Related]
6. Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer.
Suelmann BBM; Rademaker A; van Dooijeweert C; van der Wall E; van Diest PJ; Moelans CB
Cell Oncol (Dordr); 2022 Aug; 45(4):591-600. PubMed ID: 35792986
[TBL] [Abstract] [Full Text] [Related]
7. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract] [Full Text] [Related]
8. Cryptolepine Targets top2a and Inhibits Tumor Cell Proliferation in breast cancer Cells -
Mehraj U; Qayoom H; Shafi S; Farhana P; Asdaq SMB; Mir MA
Anticancer Agents Med Chem; 2022; 22(17):3025-3037. PubMed ID: 35440335
[TBL] [Abstract] [Full Text] [Related]
9. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
[TBL] [Abstract] [Full Text] [Related]
10. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer.
Wu Y; Han Y; Li Q; Zhang P; Yuan P; Luo Y; Fan Y; Chen S; Cai R; Li Q; Xu H; Wang Y; Ma F; Wang J; Xu B
Breast Cancer Res Treat; 2022 Jun; 193(2):381-392. PubMed ID: 35297009
[TBL] [Abstract] [Full Text] [Related]
11. Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with prognosis of Ovarian cancer Patients.
Li X; Wang Q; Wu Z; Zheng J; Ji L
Comput Math Methods Med; 2022; 2022():5113447. PubMed ID: 35047055
[TBL] [Abstract] [Full Text] [Related]
12. DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway.
Kulbay M; Johnson B; Fiola S; Diaz RJ; Bernier J
Biochem Pharmacol; 2021 Dec; 194():114801. PubMed ID: 34678222
[TBL] [Abstract] [Full Text] [Related]
13. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract] [Full Text] [Related]
14. [Prognostic values of spindle checkpoint protein BUB1B in triple negative breast cancer].
Zhang PC; Zhong XR; Zheng H; Li L; Chen F; Shen MJ; Li YJ; Chen H; Cao SY; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):645-649. PubMed ID: 34078054
[No Abstract] [Full Text] [Related]
15. Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer: Association with clinicopathological characteristics.
Li J; Sun P; Huang T; He S; Li L; Xue G
Medicine (Baltimore); 2021 Apr; 100(14):e25344. PubMed ID: 33832110
[TBL] [Abstract] [Full Text] [Related]
16. Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis.
Liu S; Liu X; Wu J; Zhou W; Ni M; Meng Z; Jia S; Zhang J; Guo S; Lu S; Li Y
Medicine (Baltimore); 2020 Dec; 99(49):e23153. PubMed ID: 33285689
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic and predictive value of the combination of top2a and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer.
Zhong W; Yang Y; Zhang A; Lin W; Liang G; Ling Y; Zhong J; Yong J; Liu Z; Tian Z; Lin Q; Luo Q; Li Y; Gong C
Breast Cancer; 2020 Nov; 27(6):1147-1157. PubMed ID: 32780321
[TBL] [Abstract] [Full Text] [Related]
18. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis.
Lin Y; Fu F; Lv J; Wang M; Li Y; Zhang J; Wang C
Medicine (Baltimore); 2020 Jan; 99(1):e18445. PubMed ID: 31895772
[TBL] [Abstract] [Full Text] [Related]
19. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract] [Full Text] [Related]
20. The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.
An X; Xu F; Luo R; Zheng Q; Lu J; Yang Y; Qin T; Yuan Z; Shi Y; Jiang W; Wang S
BMC Cancer; 2018 Mar; 18(1):331. PubMed ID: 29587760
[TBL] [Abstract] [Full Text] [Related]
[Next]
